results evidenced a high prevalence of antinuclear antibodies , mostly of non homogenous fluorescence in graves ' ( 63.1 % ) and hashimoto 's patients ( 65.5 % ) , as well as for antisalivary duct antibodies ( 55.2 and 75 % ) .
C0003243
antinuclear
C0003241
antibodies